AVAXIM 160 U, suspension for injection in a pre-filled syringe. vaccine of hepatitis a (inactivated, adsorbed) syringe, 0.5 ml
Active ingredients: VIRUS DE L'HÉPATITE A SOUCHE GBM INACTIVÉ ADSORBÉ
Commercialized according to BDPMDispensing in France: Prescription only
Suspension for injectionsyringe, 0.5 mlintramusculaire;sous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AVAXIM 160 U, suspension injectable en seringue préremplie. Vaccin de l'hépatite A (inactivé, adsorbé)
- Pharmaceutical form
- suspension injectable
- Route of administration
- intramusculaire;sous-cutanée
- Presentation description
- 1 seringue(s) préremplie(s) en verre de 0,5 ml avec 1 aiguille(s) attachée
- Marketing authorisation holder
- SANOFI WINTHROP INDUSTRIE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 5 Feb 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62756524CIP73416652CIP133400934166525Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VIRUS DE L'HÉPATITE A SOUCHE GBM INACTIVÉ ADSORBÉsuspension | 160 unités antigéniques · une dose de 0,5 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.